NCT04283019View on ClinicalTrials.gov

The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2021

Primary Completion Date

June 17, 2024

Study Completion Date

June 17, 2024

Conditions

Cannabis, Drug Effects

Interventions

DRUG

CBD

CBD will be orally ingested

DRUG

THC

THC will be orally ingested

Trial Locations (1)

21224

Johns Hopkins University, Baltimore

All Listed Sponsors

collaborator

Substance Abuse And Mental Health Administration

UNKNOWN

collaborator

Canopy Growth Corporation

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04283019 - The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions | Biotech Hunter | Biotech Hunter